Phenolic lipids as unique bioactive compounds: a comprehensive review on their multifunctional activity toward the prevention of Alzheimer’s disease

References

• Ahmad, W., B. Ijaz, K. Shabbiri, F. Ahmed, and S. Rehman. 2017. Oxidative toxicity in diabetes and Alzheimer’s disease: Mechanisms behind ROS/RNS generation. Journal of Biomedical Science 24 (1):76. doi:10.1186/s12929-017-0379-z
   PubMedGoogle Scholar
• Alvarez, A., C. Opazo, R. Alarco, J. Garrido, and N. C. Inestrosa. 1997. Acetylcholinesterase Promotes the Aggregation of Amyloid- b -Peptide Fragments by Forming a Complex with the Growing Fibrils. Journal of Molecular Biology 272 (3):348–61. doi:10.1006/jmbi.1997.1245
   PubMed Web of Science ®Google Scholar
• Aziz, S., and S. Kermasha. 2014. Assessment of the antioxidant capacity and oxidative stability of esterified phenolic lipids in selected edible oils. Journal of Food Science 79 (4):H730–737. doi:10.1111/1750-3841.12377
   PubMed Web of Science ®Google Scholar
• Behzadpoor, D. 2018. Alkylresorcinol in Portulaca Oleracea (Purslane) seeds as a new source of dietary phenolic lipid. A thesis submitted to the Faculty of Graduate and Postdoctoral Affairs in partial fulfillment of the requirements for the degree Master of Science at Carleton University.
   Google Scholar
• Belluti, F., L. Piazzi, A. Bisi, S. Gobbi, M. Bartolini, A. Cavalli, P. Valenti, and A. Rampa. 2009. Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry 44 (3):1341–8. doi:10.1016/j.ejmech.2008.02.035
   PubMed Web of Science ®Google Scholar
• Briou, B.,. S. Caillol, J. Robin, and V. Lapinte. 2018. Cardanol-based and formaldehyde-free flexible phenolic networks. European Journal of Lipid Science and Technology 120 (7):1800175–8. doi:10.1002/ejlt.201800175
   Web of Science ®Google Scholar
• Briuglia, M. L., C. Rotella, A. McFarlane, and D. A. Lamprou. 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Delivery and Translational Research 5 (3):231–42. doi:10.1007/s13346-015-0220-8
   PubMed Web of Science ®Google Scholar
• Bukowska, B., and S. Kowalska. 2004. Phenol and catechol induce prehemolytic and hemolytic changes in human erythrocytes. Toxicology Letters 152 (1):73–84. doi:10.1016/j.toxlet.2004.03.025
   PubMed Web of Science ®Google Scholar
• Carmichael, O. T., S. Pillai, P. Shankapal, A. Mclellan, D. G. Kay, B. T. Gold, and J. N. Keller. 2018. A combination of essential fatty acids, panax ginseng extract, and green tea catechins modifies brain FMRI signals in healthy. The Journal of Nutrition, Health & Aging 22 (7):837–46. doi:10.1007/s12603-018-1028-2
   PubMed Web of Science ®Google Scholar
• Clapp, C. H., A. Banerjee, and S. A. Rotenberg. 1985. Inhibition of soybean lipoxygenase by ar-alkylhydroxylaminest. Biochemistry 24 (8):1826–30. doi:10.1021/bi00329a004
   PubMed Web of Science ®Google Scholar
• Comorbidity, O. 2013. Leptin levels and risk of type 2 diabetes. Obesity Review 15:134–42.
   PubMed Web of Science ®Google Scholar
• Del Rio, D,. A. Rodriguez-Mateos, J. P. E. Spencer, M. Tognolini, G. Borges, and A. Crozier. 2013. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & Redox Signaling 18 (14):1818–92. doi:10.1089/ars.2012.4581
   PubMed Web of Science ®Google Scholar
• Li, S., H. J. Shin, E. L. Ding, and R. M. van Dam. 2009. Adiponectin levels and risk of type 2 diabetes. JAMA Network Jama 302 (2):179–88.
   PubMed Web of Science ®Google Scholar
• Escribá, P. V., X. Busquets, J-i Inokuchi, G. Balogh, Z. Török, I. Horváth, J. L. Harwood, and L. Vígh. 2015. Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Progress in Lipid Research 59:38–53. doi:10.1016/j.plipres.2015.04.003
   PubMed Web of Science ®Google Scholar
• Escribá, P. V. 2017. Biochimica et Biophysica Acta Membrane-lipid therapy: A historical perspective of membrane-targeted therapies — From lipid bilayer structure to the pathophysiological regulation of cells. Biochimica et Biophysica Acta (Bba) - Biomembranes 1859 (9):1493–506. doi:10.1016/j.bbamem.2017.05.017
   PubMed Web of Science ®Google Scholar
• Fang, C., L. Gu, D. Smerin, S. Mao, and X. Xiong. 2017. Review article the interrelation between reactive oxygen species and autophagy in neurological disorders. Oxidative Medicine and Cellular Longevity 2017:1–16.
   Web of Science ®Google Scholar
• Goyal, M., S. Grover, J. K. Dhanjal, S. Goyal, C. Tyagi, and A. Grover. 2014. Chemistry molecular modelling studies on flavonoid derivatives as dual site inhibitors of human acetyl cholinesterase using 3D-QSAR, pharmacophore and high throughput screening approaches. Medicinal Chemistry Research 23 (4):2122–32. doi:10.1007/s00044-013-0810-2
   Web of Science ®Google Scholar
• Greco, S. J., S. Sarkar, J. M. Johnston, and N. Tezapsidis. 2009. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochemical and Biophysical Research Communications 380 (1):98–104. doi:10.1016/j.bbrc.2009.01.041
   PubMed Web of Science ®Google Scholar
• Groemer, T. W., C. S. Thiel, M. Holt, D. Riedel, Y. Hua, J. Hüve, B. G. Wilhelm, and J. Klingauf. 2011. Amyloid precursor protein is trafficked and secreted via synaptic vesicles. PLoS One 6 (4):e18754. doi:10.1371/journal.pone.0018754
   PubMed Web of Science ®Google Scholar
• Gunenc, A., M. HadiNezhad, I. Farah, A. Hashem, and F. Hosseinian. 2015. Impact of supercritical CO 2 and traditional solvent extraction systems on the extractability of alkylresorcinols, phenolic profile and their antioxidant activity in wheat bran. Journal of Functional Foods 12:109–19. doi:10.1016/j.jff.2014.10.024
   Web of Science ®Google Scholar
• Gunenc, A., O. Rowland, H. Xu, A. Marangoni, and F. Hosseinian. 2019. Portulaca oleracea seeds as a novel source of alkylresorcinols and its phenolic profiles during germination. Lwt - Lwt 101:246–50. doi:10.1016/j.lwt.2018.10.075
   Web of Science ®Google Scholar
• Heshka, J. T., and P. J. H. Jones. 2001. A role for dietary fat in leptin receptor, OB-Rb, function. Life Sciences 69 (9):987–1003. doi:10.1016/S0024-3205(01)01201-2
   PubMed Web of Science ®Google Scholar
• Hladyszowski, J., L. Zubik, and A. Kozubek. 1998. Quantum mechanical and experimental oxidation studies of pentadecylresorcinol, olivetol, orcinol and resorcinol. Free Radical Research 28 (4):359–68. doi:10.3109/10715769809070804
   PubMed Web of Science ®Google Scholar
• Houghton, P. J., and M.-J. Howes. 2005a. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s Disease. Neurosignals 14 (1-2):6–22. doi:10.1159/000085382
   PubMedGoogle Scholar
• Houghton, P. J., and M. Howes. 2005b. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s Disease. Neurosignals 14 (1-2):6–22. doi:10.1159/000085382
   PubMedGoogle Scholar
• Hu, J., T. Lin, Y. Gao, J. Xu, C. Jiang, G. Wang, G. Bu, H. Xu, H. Chen, and Y-w Zhang. 2015. The resveratrol trimer miyabenol c inhibits β -Secretase activity and β -Amyloid generation. PLoS ONE 10 (1):e0115973–13. doi:10.1371/journal.pone.0115973
   PubMed Web of Science ®Google Scholar
• Huang, L., T. Su, W. Shan, Z. Luo, Y. Sun, F. He, and X. Li. 2012. Inhibition of cholinesterase activity and amyloid aggregation by benzoheterocyclic hybrids. Bioorganic & Medicinal Chemistry 20 (9):3038–48. doi:10.1016/j.bmc.2012.02.059
   PubMed Web of Science ®Google Scholar
• Kashima, Y., and M. Miyazawa. 2013. Structure-activity relationships for Bergenin analogues as β -Secretase (BACE1) inhibitors. Journal of Oleo Science 401 (6):391–401.
   Google Scholar
• King, A., A. Brain, K. Hanson, J. Dittmann, J. Vickers, and C. Fernandez-Martos. 2018. Disruption of leptin signalling in a mouse model of Alzheimer ‘s disease. Metabolic Brain Disease 2:1097–110.
   Google Scholar
• Kalafatakis, K,. V. Gkanti, C. A. Mackenzie-Gray Scott, A. Zarros, G. S. Baillie, and S. Tsakiris. 2015. Acetycholinesterase activity as a neurotoxicity marker within the cintext of experimentally simulated hyperprolinaesmia: An in vitro approach. Journal of Natural Science, Biology and Medicine 6 (3):98–102.
   Google Scholar
• Kubo, I., T. J. Ha, and K. Shimizu. 2013. Molecular design of soybean lipoxygenase inhibitors based on natural products. A comprehensive survey of international soybean research, chapter 8, ed. E. Board, 180–97., Berkeley, California, USA: University of California.
   Google Scholar
• Kummer, M. P., and M. T. Heneka. 2008. PPARs in Alzheimer’s disease. PPAR Research 2008:1–8. doi:10.1155/2008/403896
   Web of Science ®Google Scholar
• Kurotani, K.,. M. Sato, K. Yasuda, K. Kashima, S. Tanaka, T. Hayashi, B. Shirouchi, S. Akter, I. Kashino, H. Hayabuchi, et al. 2017. Even- and odd-chain saturated fatty acids in serum phospholipids are differentially associated with adipokines. PLoS ONE 12 (5):e0178192–14., doi:10.1371/journal.pone.0178192
   PubMed Web of Science ®Google Scholar
• Laguerre, Ml, Luis J. López Giraldo, Jérôme Lecomte, Maria-Cruz Figueroa-Espinoza, Bruno Baréa, Jochen Weiss, Eric A. Decker, and Pierre Villeneuve, 2010. Relationship between hydrophobicity and antioxidant ability of “phenolipids” in emulsion: A parabolic effect of the chain length of rosmarinate esters. Journal of Agricultural and Food Chemistry 58 (5):2869–76. doi:10.1021/jf904119v
   PubMed Web of Science ®Google Scholar
• Lee, J., Y. Pang, H. Thiermann, F. Worek, T. Wille, and F. Ekstro. 2010. Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds. Biochemical Pharmacology 80 (6):941–6.
   PubMed Web of Science ®Google Scholar
• Lemes, Laís Flávia Nunes, Giselle de Andrade Ramos, Andressa Souza de Oliveira, Fernanda Motta R. da Silva, Gina de Castro Couto, Marina da Silva Boni, Marcos Jorge R. Guimarães, Isis Nem O. Souza, Manuela Bartolini, Vincenza Andrisano, et al. 2016. Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer’s disease. European Journal of Medicinal Chemistry 108:687–700. doi:10.1016/j.ejmech.2015.12.024
   PubMed Web of Science ®Google Scholar
• Li, X., H. Yan, Y. Guo, and D. Wang. 2016. The role of leptin in central nervous system diseases. Neuroreport 27 (5):350–5.
   PubMed Web of Science ®Google Scholar
• Lu, D. C., S. Soriano, D. E. Bredesen, and E. H. Koo. 2003. Caspase cleavage of the amyloid precursor protein modulates amyloid β-protein toxicity. Journal of Neurochemistry 87 (3):733–41. doi:10.1046/j.1471-4159.2003.02059.x
   PubMed Web of Science ®Google Scholar
• Luque-Contreras, D., K. Carvajal, D. Toral-Rios, D. Franco-Bocanegra, and V. Campos-Peña. 2014. Oxidative stress and metabolic syndrome: Cause or consequence of Alzheimer’s disease? Oxidative Medicine and Cellular Longevity 2014:1–11. doi:10.1155/2014/497802
   Web of Science ®Google Scholar
• Jentoft, Mark E., and Lori A. Erickson. 2016. Alzheimer disease. Mayo Clinic Proceedings 91 (8):e117–e118. doi:10.1016/j.mayocp.2016.06.002
   PubMed Web of Science ®Google Scholar
• Martin, L., X. Latypova, and F. Terro. 2011. Post-translational modifications of tau protein: Implications for Alzheimer’s disease. Neurochemistry International 58 (4):458–71. doi:10.1016/j.neuint.2010.12.023
   PubMed Web of Science ®Google Scholar
• McGuire, Matthew J., and Makoto Ishii. 2016. Leptin dysfunction and Alzheimer’s disase: Evodence from cellular, animal and human studies. Cellular and Molecular Neurobiology 36 (2):203–17. doi:10.1007/s10571-015-0282-7
   PubMed Web of Science ®Google Scholar
• Michikawa, M. 2003. Cholesterol paradox : Is hyigh total or low HDL cholesterol level a risk for Alzheimer’s disease ? Density lipoprotein cholesterol levels are a risk for Alzheimer’s. Journal of Neuroscience Research 72 (2):141–6. doi:10.1002/jnr.10585
   PubMed Web of Science ®Google Scholar
• Mishra, P., S. R. Ayyannan, and G. Panda. 2015. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design. Chemmedchem. 10 (9):1467–74. doi:10.1002/cmdc.201500215
   PubMed Web of Science ®Google Scholar
• Pandey, A., and S. Bani. 2010. Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats. Journal of Neuroimmunology 226 (1-2):48–58. doi:10.1016/j.jneuroim.2010.05.031
   PubMed Web of Science ®Google Scholar
• Praticò, D. 2008. Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: Lights and shadows. Annals of the New York Academy of Sciences 1147 (1):70–8. doi:10.1196/annals.1427.010
   PubMedGoogle Scholar
• Ramassamy, C. 2006. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets. European Journal of Pharmacology 545 (1):51–64. doi:10.1016/j.ejphar.2006.06.025
   PubMed Web of Science ®Google Scholar
• Roleira, Fernanda M. F., Christophe Siquet, Elizabeta Orrù, E. Manuela Garrido, Jorge Garrido, Nuno Milhazes, Gianni Podda, Fátima Paiva-Martins, Salette Reis, Rui A. Carvalho, et al. 2010. Lipophilic phenolic antioxidants : Correlation between antioxidant profile, partition coefficients and redox properties. Bioorganic & Medicinal Chemistry 18 (16):5816–25. doi:10.1016/j.bmc.2010.06.090
   PubMed Web of Science ®Google Scholar
• Sang, Zhipei, Keren Wang, Huifang Wang, Huijuan Wang, Qianwen Ma, Xue Han, Mengyao Ye, Lintao Yu, and Wenmin Liu. 2017. Design, synthesis and biological evaluation of 2-acetyl-5- O - (amino- alkyl) phenol derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters 27 (22):5046–52. doi:10.1016/j.bmcl.2017.09.057
   PubMed Web of Science ®Google Scholar
• Schwartz, M., O. Butovsky, and J. Kipnis. 2006. Does Inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. Journal of Neuroimmune Pharmacology 1 (1):4–10. doi:10.1007/s11481-005-9010-2
   PubMed Web of Science ®Google Scholar
• Shang, E., Y. Liu, Y. Wu, W. Zhu, C. He, and L. Lai. 2014. Development of 3, 5-dinitrobenzoate-based 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry 22 (8):2396–402. doi:10.1016/j.bmc.2014.03.008
   PubMed Web of Science ®Google Scholar
• Solomon, A., F. Mangialasche, E. Richard, S. Andrieu, D. A. Bennett, M. Breteler, L. Fratiglioni, B. Hooshmand, A. S. Khachaturian, L. S. Schneider, et al. 2014. Advances in the prevention of Alzheimer’s disease and dementia. Journal of Internal Medicine 275 (3):229–50., doi:10.1111/joim.12178
   PubMed Web of Science ®Google Scholar
• Sorour, N., S. Karboune, R. Saint-Louis, and S. Kermasha. 2012. Enzymatic synthesis of phenolic lipids in solvent-free medium using flaxseed oil and 3, 4-dihydroxyphenyl acetic acid. Process Biochemistry 47 (12):1813–9. doi:10.1016/j.procbio.2012.06.020
   Web of Science ®Google Scholar
• Stasiuk, M., D. Bartosiewicz, and A. Kozubek. 2008. Inhibitory effect of some natural and semisynthetic phenolic lipids upon acetylcholinesterase activity. Food Chemistry 108 (3):996–1001. doi:10.1016/j.foodchem.2007.12.011
   PubMed Web of Science ®Google Scholar
• Stasiuk, M., M. Kleta, and A. Kozubek. 2011. Dual effect of free and liposomal forms of phenolic lipids on the activity of GPI-anchor-deprived acetylcholinesterase from erythrocytes. Food Chemistry 125 (2):508–12. doi:10.1016/j.foodchem.2010.09.041
   Web of Science ®Google Scholar
• Stasiuk, M., and A. Kozubek. 2010. Biological activity of phenolic lipids. Cellular and Molecular Life Sciences 67 (6):841–60. doi:10.1007/s00018-009-0193-1
   PubMed Web of Science ®Google Scholar
• Straus, D. S., and C. K. Glass. 2007. Anti-inflammatory actions of PPAR ligands : new insights on cellular and molecular mechanisms. Trend in Immunology 28 (12):551–58.
   PubMed Web of Science ®Google Scholar
• Suh, W. H., K. S. Suslick, and Y. Suh. 2005. Therapeutic agents for Alzheimer’s disease. Current Medicinal Chemistry-Central Nervous System Agents 5 (4):259–69. doi:10.2174/156801505774913035
   Google Scholar
• Tõugu, Vello, and Tõnu Kesvatera. 2001. Comparison of salt effect on the reactions of acetylcholinesterase with cationic and anionic inhibitors. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1544 (1-2):189–95. doi:10.1016/S0167-4838(00)00218-1
   PubMedGoogle Scholar
• Tsuchiya, H. 2015. Membrane interactions of phytochemicals as their molecular mechanism applicable to the discovery of drug leads from plants. Molecules 20 (10):18923–66. doi:10.3390/molecules201018923
   PubMed Web of Science ®Google Scholar
• Vlachogianni, I. C., E. Fragopoulou, I. K. Kostakis, and S. Antonopoulou. 2015. In vitro assessment of antioxidant activity of tyrosol, resveratrol and their acetylated derivatives. Food Chemistry 177:165–73. doi:10.1016/j.foodchem.2014.12.092
   PubMed Web of Science ®Google Scholar
• Yu, Liang, Rihui Cao, Wei Yi, Qin Yan, Zhiyong Chen, Lin Ma, Wenlie Peng, and Huacan Song. 2010. Synthesis of 4- [(diethylamino) methyl] -phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase. Bioorganic & Medicinal Chemistry Letters 20 (11):3254–8. doi:10.1016/j.bmcl.2010.04.059
   PubMed Web of Science ®Google Scholar
• Zawilska, P., and K. Cie. 2017. Laurdan emission study of the cholesterol-like effect of long-chain alkylresorcinols on the structure of dipalmitoylphosphocholine and sphingomyelin membranes. Biophysical Chemistry 221:1–9. doi:10.1016/j.bpc.2016.11.004
   PubMed Web of Science ®Google Scholar
• Zhong, Y., and F. Shahidi. 2012. Lipophilised epigallocatechin gallate (EGCG) derivatives and their antioxidant potential in food and biological systems. Food Chemistry 131 (1):22–30. doi:10.1016/j.foodchem.2011.07.089
   Web of Science ®Google Scholar
• Zhou, Z. L., Y. Ho, H. L. Liu, P. Elumalai, and W. H. Chen. 2015. Computer-aided discovery of novel non-peptide inhibitors against amyloid-beta (Aβ) peptide aggregation for treating Alzheimer’s disease. Molecular Simulation 41 (8):622–32. doi:10.1080/08927022.2014.910600
   Web of Science ®Google Scholar